期刊文献+

多囊卵巢综合征与高同型半胱氨酸血症相关性的研究进展 被引量:5

Advances of correlations between polycystic ovary syndrome and hyperhomocysteinemia
下载PDF
导出
摘要 多囊卵巢综合征(polycystic ovary syndrome,PCOS)是一组以内分泌代谢紊乱为主的综合征,临床表现主要包括月经稀发、排卵障碍、高雄激素血症以及卵巢多囊样改变。PCOS患者发生2型糖尿病、动脉硬化以及心血管疾病的风险增加,这主要和PCOS患者体内各种因素导致的胰岛素代谢紊乱和血管内皮系统损伤有关。同型半胱氨酸(homocysteine,HCY)作为血管内皮损伤的标志之一,是心血管疾病发病的独立危险因素,PCOS患者往往伴有高同型半胱氨酸血症(hyperhomocysteinemia,HHCY),这可能是导致PCOS患者心血管并发症的重要因素之一。目前PCOS患者体内HCY水平升高的机制尚未完全清楚,现就国内外这方面的研究进展做一综述。 Polycystic ovary syndrome (PCOS) is a common endocrine disorder which involves oligomenorrhea, ovulatory problems, hyperandrogenism, and polycystic ovary. The women with PCOS may have some remote complications such as type 2 diabetes metlitus, atherosclerosis, and cardiovascular disease. All these complications may partly attribute to hyperinsulinemia, insulin resistance, and dysfunction of endothelial system. Homocysteine (HCY), one of the most important marks reflecting endothelial dysfunction, is an independent risk factor of cardiovascular disease. And this may be an important cardiovascular disease risk factor for women with PCOS since these women are probably subjected to hyperhomocysteinemia (HHCY). So far.it' s not well known why women with PCOS are subjected to HHCY. This paper reviews the progress in this aspect of research, and here giving some possible suggestions.
出处 《生殖医学杂志》 CAS 2013年第8期626-632,共7页 Journal of Reproductive Medicine
基金 军队"十一五"科技攻关课题(06G006)
关键词 多囊卵巢综合征 高同型半胱氨酸血症 Polycystic ovary syndrome Hyperhomocysteiriemia
  • 相关文献

参考文献39

  • 1陈子江,刘嘉茵.多囊卵巢综合征--基础理论与临床[M].第3版.北京:人民卫生出版社,2009:2-10.
  • 2Kilic Okrnan T, Guldiken S, Kucuk M. Relationshi Pbetween homoeysteine and insulin resistance in women with polyeystic ovary syndrorne[J].Endocr J, 2004,51 : 505-508.
  • 3Papatheodorou L, Weiss N. Vascular oxidant stress and inflammation in hyperhomocysteinemia[J]. Antioxid Redox Signal, 2007,9 : 1941-1958.
  • 4Benkhalifa M, Montjean D, Cohen-Baerie P, et al. Irnprinting:RNA expression for homocysteine recycling in the human ooeyte[J]. Fertil Steril, 2010,93 : 1585-1590.
  • 5Yakub M, Moti N, Parveen S, et al. Polyrnorphisrns in MTHFR, MS and CBS genes and homocysteine levels in a Pakistani population[OL]. PLoS One, 2012,7 : e33222.
  • 6Orio FJ, Palomba S, Di Blase S, et al. Hornocysteine levels and C677T polymorphism of methylenetetrahydrofolatereductase in women with polycystic ovary syndrome[J]. J Clin Endocrinol Metab,2003,88 : 673-679.
  • 7Karadeniz M, Erdogan M, Zengi A, et al. Methylenetetrahydrofolate reductase C677T gene polymorphism in Turkish patients with polycystic ovary syndrome[J]. Endocrine, 2010,38 : 127-133.
  • 8Palep-Singh M, Pieton HM, Yates ZR, et al. Polycystic ovary syndrome and the single nucleoti de polymorphisms of methylenetctrahydrofolate reductase: a pilot observational study[J]. Hum Fertil (Camb) ,2007,10:33-41.
  • 9Idali F, Zareii S, Mohammad-Zadeh A, et al. Plasminogen activator inhibitor 1 and methylenetetrahydrofolate reductase gene mutations in iranian women with polycystic ovary syndrome[J]. Am J Reprod Immunol, 2012,68 : 400-407.
  • 10Laraqui A, Allami A, Carrie A, et al. Influence of methioninc synthase (A2756G) and methionine synthase reductase (A66G) polymorphisms on plasma homoeysteine levels and relation to risk of coronary artery disease[J]. Acta Cardiol, 2006,61 : 51-61.

二级参考文献23

共引文献6

同被引文献34

引证文献5

二级引证文献32

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部